The Pan-Immune-Inflammation Value predicts the survival of patients with anaplastic lymphoma kinase-positive non-small cell lung cancer treated with first-line ALK inhibitor-Reference-Cited by-同舟云学术

The Pan-Immune-Inflammation Value predicts the survival of patients with anaplastic lymphoma kinase-positive non-small cell lung cancer treated with first-line ALK inhibitor

Published:2022-03 Issue: Volume:17 Page:101338
ISSN:1936-5233
Container-title:Translational Oncology
language:en
Short-container-title:Translational Oncology

Author:

Chen Xinru,Hong Xiangchan,Chen Gang,Xue Jinhui,Huang Jie,Wang Fan,Ali Wael Ab dullah Sultan,Li Jing,Zhang Li

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference41 articles.

1. The incidence and mortality of lung cancer and their relationship to development in Asia;Pakzad;Transl. Lung Cancer Res.,2015

2. EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer;Koivunen;Clin. Cancer Res.,2008

3. ALK inhibitors in the treatment of advanced NSCLC;Gridelli;Cancer Treat. Rev.,2014

4. First-line crizotinib versus chemotherapy in ALK-positive lung cancer;Solomon;N. Engl. J. Med.,2014

5. Updated efficacy and safety data and impact of the EML4-ALK fusion variant on the efficacy of alectinib in untreated ALK-positive advanced non-small cell lung cancer in the global phase III ALEX study;Camidge;J. Thorac. Oncol.,2019

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Prognostic Role of SIRI and PIV in Patients with Metastatic Non-Small Cell Lung Cancer Receiving Systemic Chemotherapy;2024-08-26

2. Assessing the prognostic role of panimmune inflammation in high-grade gliomas;Clinical and Translational Oncology;2024-08-14

3. The Baseline Pan-Immune‑Inflammation Value (PIV) and PILE in Predicting Clinical Outcomes and Therapeutic Response for Primary Central Nervous System Lymphoma;Journal of Inflammation Research;2024-08

4. Evaluation of pan-Immuno-Inflammation value for In-hospital mortality in acute pulmonary embolism patients;Revista de investigaci�n Cl�nica;2024-05-06

5. Utility of Pan-Immune-Inflammatory Value and Lactate for Determining Surgical Indications for Portal Venous Gas and Intestinal Pneumatosis;The Japanese Journal of Gastroenterological Surgery;2024-03-01